Yuichi Oike - Genetic Mutations

Author Information

Yuichi Oike is a distinguished researcher affiliated with the Department of Molecular Genetics at the Graduate School of Medical Sciences, Kumamoto University, located in Kumamoto, Japan. His extensive research in the field of genetics has significantly contributed to our understanding of various molecular and cellular processes.

Research Contributions

Yuichi Oike has made substantial contributions to the field of genetics, particularly in understanding the molecular mechanisms underlying diseases and therapeutic interventions. His recent research includes studies on plasma angiopoietin-like protein 2 levels and their association with mortality risk, targeting chemoresistance in renal cell carcinoma, and the role of lncRNA in heart failure. His work also spans investigations into angiopoietin-like proteins in chronic heart failure, peritoneal metastasis of ovarian cancer, and leptin signaling in the hypothalamus, among others.

Aliases

Yuichi Oike has published under various aliases, including Y. Oike and Y Oike. These aliases represent the same researcher and are commonly used in different publications.

Publication and Citation Metrics

Metric	Value
Total Papers	284
Total Citations	17,302
h-index	76

Publications:

Plasma angiopoietin-like protein 2 levels and mortality risk among younger-old Japanese people: a population-based case-cohort study.

DOI: 10.1093/gerona/glac017

Year: 2022

Targeting chemoresistance in Xp11.2 translocation renal cell carcinoma using a novel polyamide-chlorambucil conjugate.

DOI: 10.1111/cas.15364

Year: 2022

The lncRNA Caren antagonizes heart failure by inactivating DNA damage response and activating mitochondrial biogenesis

DOI: 10.1038/s41467-021-22735-7

Year: 2021

Hyperglycemia and Thrombocytopenia　― Combinatorially Increase the Risk of Mortality in Patients With Acute Myocardial Infarction Undergoing Veno-Arterial Extracorporeal Membrane Oxygenation ―

DOI: 10.1253/circrep.cr-21-0043

Year: 2021

Serum Angiopoietin-Like Protein 2 and NT-Pro BNP Levels and Their Associated Factors in Patients with Chronic Heart Failure Participating in a Phase III Cardiac Rehabilitation Program.

DOI: 10.1536/ihj.21-106

Year: 2021

Angiopoietin-like protein 2 decreases peritoneal metastasis of ovarian cancer cells by suppressing anoikis resistance.

DOI: 10.1016/j.bbrc.2021.05.008

Year: 2021

Angiopoietin-Like Growth Factor Involved in Leptin Signaling in the Hypothalamus

DOI: 10.3390/ijms22073443

Year: 2021

Identification and Clinical Associations of 3 Forms of Circulating T-cadherin in Human Serum

DOI: 10.1210/clinem/dgab066

Year: 2021

Dysfunction of the proteoglycan Tsukushi causes hydrocephalus through altered neurogenesis in the subventricular zone in mice

DOI: 10.1126/scitranslmed.aay7896

Year: 2021

Vaccine targeting ANGPTL3 ameliorates dyslipidemia and associated diseases in mouse models of obese dyslipidemia and familial hypercholesterolemia

DOI: 10.1016/j.xcrm.2021.100446

Year: 2021

What are DNA Replication Errors?

What Challenges Exist in Using Genetic Information for Medication Management?

What is CFTR Protein?

What Are the Challenges in Pharmacogenomics?

How Do Mutations Lead to Evolutionary Change?

What Are the Biological Consequences of UV-Induced Mutations?

How Does Sickle Cell Disease Affect Population Genetics?

How Do Beneficial Mutations Spread in Populations?

What are the Ethical Concerns?

What are Viral Vectors?

Partnered Content Networks

Relevant Topics